Nonsteroidal Anti-Inflammatory Drugs and the Kidney
- PMID: 27713354
- PMCID: PMC4036662
- DOI: 10.3390/ph3072291
Nonsteroidal Anti-Inflammatory Drugs and the Kidney
Abstract
Non-steroidal anti-inflammatory drugs (NSAIDs) inhibit the isoenzymes COX-1 and COX-2 of cyclooxygenase (COX). Renal side effects (e.g., kidney function, fluid and urinary electrolyte excretion) vary with the extent of COX-2-COX-1 selectivity and the administered dose of these compounds. While young healthy subjects will rarely experience adverse renal effects with the use of NSAIDs, elderly patients and those with co-morbibity (e.g., congestive heart failure, liver cirrhosis or chronic kidney disease) and drug combinations (e.g., renin-angiotensin blockers, diuretics plus NSAIDs) may develop acute renal failure. This review summarizes our present knowledge how traditional NSAIDs and selective COX-2 inhibitors may affect the kidney under various experimental and clinical conditions, and how these drugs may influence renal inflammation, water transport, sodium and potassium balance and how renal dysfunction or hypertension may result.
Keywords: acute renal failure; celecoxib; chronic kidney disease; cyclooxygenase; non-steroidal anti-inflammatory drugs.
Similar articles
-
[Case report: reversible acute renal failure following therapy with both ketorolac (non-selective non-steroidal anti-inflammatory drug NSAID) and celecoxib (COX-2 selective) in the same patient].G Ital Nefrol. 2002 Mar-Apr;19(2):199-203. G Ital Nefrol. 2002. PMID: 12195419 Italian.
-
COX-2-Specific inhibitors--the emergence of a new class of analgesic and anti-inflammatory drugs.Clin Rheumatol. 2000;19(5):331-43. doi: 10.1007/s100670070024. Clin Rheumatol. 2000. PMID: 11055820 Review.
-
Anti-inflammatory agents and renal function.Semin Arthritis Rheum. 2002 Dec;32(3 Suppl 1):33-42. doi: 10.1053/sarh.2002.37216. Semin Arthritis Rheum. 2002. PMID: 12528072 Review.
-
A comparison of renal-related adverse drug reactions between rofecoxib and celecoxib, based on the World Health Organization/Uppsala Monitoring Centre safety database.Clin Ther. 2001 Sep;23(9):1478-91. doi: 10.1016/s0149-2918(01)80121-1. Clin Ther. 2001. PMID: 11589261
-
Effect of nonsteroidal anti-inflammatory drugs with varying extent of COX-2-COX-1 selectivity on urinary sodium and potassium excretion in the rat.Can J Physiol Pharmacol. 2005 Jan;83(1):85-90. doi: 10.1139/y04-129. Can J Physiol Pharmacol. 2005. PMID: 15759054
Cited by
-
Non-steroidal anti-inflammatory drugs in chronic kidney disease and risk of acute adverse kidney events according to route of administration.Int Urol Nephrol. 2023 Mar;55(3):679-686. doi: 10.1007/s11255-022-03344-9. Epub 2022 Sep 5. Int Urol Nephrol. 2023. PMID: 36065044
-
Risk Factors for End-Stage Renal Failure Among Patients on Hemodialysis in Aljomhory Hospital, Sa'adah Governorate, Yemen: Hospital-Based Case-Control Study.JMIR Public Health Surveill. 2019 Sep 25;5(3):e14215. doi: 10.2196/14215. JMIR Public Health Surveill. 2019. PMID: 31573930 Free PMC article.
-
A Classic Herbal Formula Danggui Beimu Kushen Wan for Chronic Prostatitis: From Traditional Knowledge to Scientific Exploration.Evid Based Complement Alternat Med. 2018 Nov 13;2018:1612948. doi: 10.1155/2018/1612948. eCollection 2018. Evid Based Complement Alternat Med. 2018. PMID: 30538755 Free PMC article. Review.
-
Pathophysiological aspects of nephropathy caused by non-steroidal anti-inflammatory drugs.J Bras Nefrol. 2019 Jan-Mar;41(1):124-130. doi: 10.1590/2175-8239-JBN-2018-0107. Epub 2018 Sep 21. J Bras Nefrol. 2019. PMID: 30281062 Free PMC article. Review.
-
The Risk of Nonsteroidal Anti-Inflammatory Drugs in Pediatric Medicine: Listen Carefully to Children with Pain.Children (Basel). 2021 Nov 13;8(11):1048. doi: 10.3390/children8111048. Children (Basel). 2021. PMID: 34828761 Free PMC article.
References
-
- Singh G., Triadafilopoulos G. Epidemiology of NSAID induced gastrointestinal complications. J. Rheumatol. 1999;56:18–24. - PubMed
-
- Gambaro G., Perazella M.A. Adverse renal effects of anti-inflammatory agents: evaluation of selective and nonselective cyclooxygenase inhibitors. J. Intern. Med. 2003;253:643–652. - PubMed
-
- Sandhu G.K., Heyneman C.A. Nephrotoxic potential of selective cyclooxygenase-2 inhibitors. Ann. Pharmacother. 2004;38:700–704. - PubMed
-
- Harris R.C. COX-2 and the Kidney. J. Cardiovasc Pharmacol. 2006;47:S37–S42. - PubMed
-
- de Leval X., Hanson J., David J.L., Masereel B., Pirotte B., Dogné J.M. New developments on thromboxane and prostacyclin modulators part II: prostacyclin modulators. Curr. Med. Chem. 2004;11:1243–1252. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
